Musculoskeletal Diseases Orthopaedics
Conditions
Interventions
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: Competitive team-sport athletes Male or female participants Adults aged 18 years or older Right-handed participants Participants involved in handball, basketball, or volleyball Able to provide written informed consent Able to complete maximal voluntary contraction and sustained isometric elbow-flexor exercise testing
Exclusion criteria
Exclusion criteria: Current upper-limb musculoskeletal injury or pain History of neurological, neuromuscular, cardiovascular, or metabolic disease Previous surgery or major injury affecting the tested upper limb Contraindication to percutaneous electrical nerve stimulation Use of medication or treatment likely to affect neuromuscular function or fatigue responses Inability to comply with the immobilization protocol or study testing procedures Participation in structured physical training during the intervention period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Exercise-induced change in maximal voluntary contraction (MVC) force of the non-dominant elbow flexors, used as the main indicator of performance fatigability. MVC was measured using an isometric dynamometer before and immediately after a sustained isometric contraction at 50% MVC until exhaustion. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes included time to task failure during the sustained isometric elbow-flexor contraction at 50% MVC potentiated twitch force of the biceps brachii as an index of peripheral neuromuscular fatigue; voluntary activation as an index of central neuromuscular fatigue; biceps brachii electromyographic activity normalized to maximal M-wave amplitude (RMS/Mmax) maximal M-wave amplitude as an indicator of neuromuscular propagation and membrane excitability and upper-arm muscle and bone area estimated from anthropometric measurements. | — |
Countries
Tunisia
Contacts
Associate Professor